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Disrupted-in-schizophrenia 1 (DISC1) is a genetic susceptibility factor for schizophrenia and related severepsychiatric conditions.DISC1
is a multifunctional scaffold protein that is able to interact with several proteins, including the independently identified schizophrenia
risk factor phosphodiesterase-4B (PDE4B). Here we report that the 100 kDa full-length DISC1 isoform (fl-DISC1) can bind members of
each of the four gene, cAMP-specific PDE4 family. Elevation of intracellular cAMP levels, so as to activate protein kinase A, caused the
release of PDE4D3 and PDE4C2 isoforms from fl-DISC1 while not affecting binding of PDE4B1 and PDE4A5 isoforms. Using a peptide
array strategy, we show that PDE4D3 binds fl-DISC1 through two regions found in common with PDE4B isoforms, the interaction of
which is supplemented because of the presence of additional PDE4B-specific binding sites. We propose that the additional binding sites
found inPDE4B1underpin its resistance to releaseduring cAMPelevation.We identify, for the first time, a functional distinctionbetween
the 100 kDa longDISC1 isoformand the short 71 kDa isoform.Thus, changes in the expressionpattern ofDISC1 andPDE4 isoformsoffers
a means to reprogram their interaction and to determine whether the PDE4 sequestered by DISC1 is released after cAMP elevation. The
PDE4B-specific binding sites encompasspointmutations inmouseDisc1 that conferphenotypes related to schizophrenia anddepression
and that affect binding to PDE4B. Thus, genetic variation in DISC1 and PDE4 that influence either isoform expression or docking site
functioning may directly affect psychopathology.
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Introduction
The discovery of a balanced chromosomal translocation cosegre-
gating with major psychiatric disorders identified a lesion within
the open reading frame (ORF) of disrupted-in-schizophrenia 1
(DISC1), leading to the DISC1 locus being identified as a risk
factor for schizophrenia and other mental illnesses (Porteous et
al., 2006). DISC1 has now been demonstrated to influence brain
structure and cognitive function (Hashimoto et al., 2006; Liu et
al., 2006; Porteous and Millar, 2006; Qu et al., 2007).
DISC1 encodes a full-length 100 kDa protein (fl-DISC1)
with various uncharacterized isoforms generated by alternative
splicing (Porteous andMillar, 2006). In brain, DISC1 is localized
predominantly within regions implicated in the pathogenesis of
psychiatric illness (Porteous and Millar, 2006). DISC1 acts as a
scaffold protein, interacting with various proteins including
those involved in neuronal migration (NUDEL and LIS1) and
neurite extension (FEZ1) (Morris et al., 2003; Ozeki et al., 2003;
Brandon et al., 2004; Miyoshi et al., 2004; Kamiya et al., 2005;
Camargo et al., 2007; Shinoda et al., 2007; Taya et al., 2007),
indicating a critical involvement in brain development and
function.
cAMP plays a key role in many aspects of neuronal function
and, recently, DISC1 has been shown to bind cAMP-specific
phosphodiesterase-4B (PDE4B) (Millar et al., 2005). Four genes
(A/B/C/D) encode the PDE4 family, with alternative mRNA
splicing generating20 isoforms (Conti et al., 2003;Houslay and
Adams, 2003; Houslay et al., 2005). Long isoforms exhibit two
conserved regions called UCR1 and UCR2, with UCR1 contain-
ing a site for stimulatory phosphorylation by protein kinase A
(PKA) (Sette et al., 1994; MacKenzie et al., 2002).
The PDE4B gene is an independent risk factor for psychiatric
illness (Millar et al., 2005). Indeed, genetic variantswithinPDE4B
(Pickard et al., 2007) and also within PDE4D (Tomppo et al.,
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2006) associate with schizophrenia, suggesting a general involve-
ment of PDE4 isoforms in conferring susceptibility to major
mental illness. PDE4 genes are orthologous toDrosophila dunce, a
gene involved in learning andmemory (Davis et al., 1995).More-
over, PDE4-selective inhibitors exert potent antidepressant ac-
tions, whereas mice deficient in PDE4B and PDE4D behave as if
on antidepressants (O’Donnell and Zhang, 2004; Zhang et al.,
2005, 2006). Additionally, chronic nicotine treatment, which can
exert antidepressant actions, selectively downregulates PDE4B in
various brain regions (Polesskaya et al., 2007). Furthermore,
PDE4-regulated cAMP signaling is of crucial importance for the
protection, growth, and myelination of injured CNS axons (Gao
et al., 2003; Nikulina et al., 2004; Pearse et al., 2004).
Here we analyze the 100 kDa fl-DISC1 isoform to identify
PDE4 subfamily-specific differences in interaction and cAMP-
mediated release from fl-DISC1. We show that increased cAMP
levels cause release of PDE4D isoforms from fl-DISC1, whereas
PDE4B isoforms remain stably associated. Insight into the basis
of these selective actions comes from our use of a novel peptide
array approach (Bolger et al., 2006; Baillie et al., 2007) to show
that fl-DISC1 has two binding sites that PDE4 isoforms bind in
common, together with additional N-terminal sites specific for
PDE4B.
Materials andMethods
Materials.Allmaterials for tissue culture were supplied by Sigma-Aldrich
(Dorset, UK). L-[ 35S]-Methionine (1000 Ci/mmol), [ 32P]orthophos-
phate (200mCi/mmol), and protein G–Sepharose beads were purchased
from Amersham Biosciences (Buckinghamshire, UK). Anti-FLAG M2
monoclonal antibody, anti-maltose binding protein (MBP) antibody,
anti-glutathione S-transferase (GST) antibody, forskolin, 3-isobutyl-1-
methylxanthine (IBMX), and epidermal growth factor (EGF) were from
Sigma-Aldrich; anti-myc tag 9E10, anti- extracellular signal-regulated
kinase 1/2 (Erk1/2), and anti-phospho-Erk1/2 antibodies were fromUp-
state (Paisley, UK); polyclonal anti-EPAC (exchange protein activated by
cAMP) antibody was from Santa Cruz Biotechnology (Wiltshire, UK);
EPAC agonist (8-pCPT-2-O-Me-cAMP) was from Biolog (Bremen,
Germany). Antisera specific for DISC1, PDE4A, PDE4B, PDE4C, and
PDE4Dhave been described previously (Huston et al., 1996, 1997; Bolger
et al., 1997;MacKenzie andHouslay, 2000;MacKenzie et al., 2002; James
et al., 2004; Ogawa et al., 2005). Stearoyl DISC1 peptides were generated
as described previously (Hundsrucker et al., 2006). These were stearoyl–
SHSAFTSSFSFIRLSLGSAGERGE (CS1P) and stearoyl–IRSLTSERE-
GLEGLLSKLLVLSSRN (CS2P).
Mammalian expression constructs. Plasmids encoding FLAG-DISC1,
mycHIS-fl-DISC1, mycHIS-(1–187)-DISC1, PKA inhibitory peptide
PKI, and PDE4 constructs PDE4A5, PDE4B1, PDEB2, PDEB3, PDE4C2,
PDE4D3, PDE4D5, PDE4D3S54A, PDE4D3S54E, PDE4D3S13AS54A,
and PDE4D-CAT have been described previously (Huston et al., 1996,
1997; Bolger et al., 1997; Owens et al., 1997; Hoffmann et al., 1998; Beard
et al., 2000; Brandon et al., 2004; Fleming et al., 2004; Millar et al., 2005).
DISC1 regions comprising residues 220–283 and 359–854 were sub-
cloned into pEBG-2T vector to generate GST fusion proteins for expres-
sion in mammalian cells. A T744A site mutation in the FLAG-DISC1
ORF was introduced using the QuikChange II site-directed mutagenesis
kit (Stratagene, Amsterdam, The Netherlands) according to the manu-
facturer’s instructions with the following primers: T744A-sense (5-
ACTCCGAGGATAAAAGGAAGGCCCCTTTGAAGGTATTGGAA-3)
and T744A-antisense (5-TTCCAATACCTTCAAAGGGGCCTTCC-
TTTTATCCTCGGAGT-3).Mutagenesis was verified by sequencing be-
fore use.
Bacterial expression constructs. ORFs of PDE4B1 and PDE4D3 were
subcloned into pMALC2 vector (New England Biolabs, Hertfordshire,
UK) to generate N-terminalMBP fusion proteins. Similarly, the ORFs of
PDE4B2 and individual PDE4D domains, UCR1, UCR2, and a catalytic
(CAT) unit were subcloned into pGEX-5X-3 vector (Invitrogen, Paisley,
UK) and expressed as N-terminal GST fusion proteins.
Cell culture and transient transfection. Cell lines HEK293, COS1, and
SHSY5Y were maintained in DMEM supplemented with 10% fetal calf
serum (FCS), 10,000U/ml penicillin/streptomycin, and 2mM glutamine.
Cell lines were transfected using Lipofectamine 2000 reagent (Invitro-
gen) according to recommended protocols. Forskolin, IBMX, EPAC ag-
onist, and EGFwere added to cultures at 100M, 100M, 10M, and 200
ng/ml, respectively, and incubated at 37°C for 15 min before harvesting
of cells.
Immunoprecipitation and immunoblotting.Cells were washed with ice-
cold PBS and lysed in PBS containing 1%TritonX-100, 1mMdithiothre-
itol (DTT), 10 mM NaF, and 5 mM NaPPi with a protease inhibitor
mixture added (Roche, West Sussex, UK). Lysates were solubilized by
rotation on a rotary wheel for 30 min at 4°C. Insoluble material was
removed by a 15 min centrifugation at 14,000 gav at 4°C, followed by
preclearing of lysed supernatants by incubation with protein G–Sepha-
rose beads for 30 min at 4°C. Equalized amounts of precleared lysates
were incubated with the indicated antibody for aminimum of 3 h at 4°C,
and immunocomplexes were captured after incubation with protein
G–Sepharose beads for an additional 1–2 h. The immunoprecipitates
were washed three times in lysis buffer and eluted from the beads by the
addition of Laemmli buffer (LB) (Laemmli, 1970).
For immunoblotting, proteins were resolved by SDS-PAGE and trans-
ferred to nitrocellulose membranes. Membranes were blocked with 5%
low-fatmilk powder in TBS (10mMTris-HCl, pH 7.4, and 150mMNaCl)
for 1 h at room temperature and incubated with the indicated primary
antibody (in 1% low-fat milk powder, TBS, and 0.1% Tween 20) for 1 h
at room temperature. Bound antibody was detected with the comple-
mentary horseradish peroxidase (HRP)-conjugated secondary antibody
(Sigma-Aldrich), and proteins were visualized using enhanced chemilu-
minescence (Pierce, Northumberland, UK).
Confocal microscopy and immunofluorescence staining. Cells were
transfected on coverslips in six-well plates and the following day were
fixed in 4% paraformaldehyde in TBS containing 5% sucrose for 10 min
at room temperature. Cells were then permeabilized by performing three
5min incubations with 0.2% Triton X-100/TBS, followed by three 5min
incubations with blocking buffer (10% donkey serum and 2% BSA).
Coverslips were incubated for 2 h at room temperature with antisera
specific for cAMP-activated EPAC at the required concentration in di-
lutant buffer (blocking buffer diluted 50% with TBS). After three addi-
tional washes with blocking buffer, coverslips were incubated for 1 hwith
the complementary Alexa594-conjugated secondary antibody. After fur-
ther washing with TBS, coverslips were mounted onto glass slides and
observed using a Zeiss (Oberkochen, Germany) Pascal laser-scanning
confocal microscope.
Treatment with DISC1 stearoyl peptides. Cells coexpressing fl-DISC1
with either PDE4D3 or PDE4B1 were pretreated with the peptides at a
concentration of 50M inMe2SO for 2–3 h before challenge with 100M
forskolin and 100 M IBMX for 15 min. Control cells were pretreated
with the equivalent concentration of Me2SO (0.2%).
Purification of MBP and GST fusion proteins. Bacterial expression con-
structs were transformed into Escherichia coli BL21 cells. A 10 ml starter
culture was used to inoculate 400 ml of LB medium containing 100
g/ml ampicillin andwas grown at 37°Cuntil the culture reached anA600
of 0.5. Expression of the fusion proteins was induced by the addition of 1
mM isopropyl-,D-thiogalactopyranoside for 4 h before cells were har-
vested by centrifugation at 10,000  gav for 15 min at 4°C. Pellets were
then lysed in 20ml of STE buffer (10mMTris-HCl, pH 8.0, 150mMNaCl,
and 1 mM EDTA) containing 1 mg/ml lysozyme and incubated with
rotation at 4°C for 1 h. DTT to a final concentration of 5 mM and 10%
Sarkosyl in STE buffer to a final concentration of 1.5% were added to
lysates before sonication for 1min. The removal of insolublematerial was
performed by a 15min centrifugation at 10,000 gav at 4°C. Ten percent
Triton X-100 in STE buffer to a final concentration of 2% and a mixture
of protease inhibitors were added to the cleared supernatants and stored
at80°C until used.
MBP and GST fusion protein-cleared lysates were added to 500 l of
amylose resin (New England Biolabs) and 500 l of glutathione–Sepha-
rose beads (Amersham Biosciences), respectively, and incubated for 2 h
at 4°C. Beadswere pelleted by centrifugation (10,000 gav for 1min) and
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washed three times in PBS/1% Triton X-100 with protease inhibitors
added. The MBP fusion proteins were eluted from the beads by three
incubations of 30 min at 4°C with 600 l of STE buffer plus 10 mM
maltose. Using a similar protocol, GST fusion proteins were eluted with
30 mM glutathione in STE buffer. The eluted fractions were pooled and
dialyzed for at least 18 h at 4°C against three changes of dialysis buffer (20
mM Tris-HCl, pH 7.6, and 50 mMNaCl; 2 L total volume) before storage
at80°C.
In vitro protein synthesis. [ 35S]-labeled FLAG-DISC1 protein was syn-
thesized using the T7 transcription/translation-coupled reticulocyte ly-
sate system (Promega, Hampshire, UK). The translation product was
partially purified by ammonium sulfate precipitation as described previ-
ously (Bardwell et al., 1992) before use in peptide array analyses.
Spot synthesis of peptides and overlay experiments.Peptide librarieswere
produced by automatic Spot synthesis as described by us previously
(Bolger et al., 2006; Baillie et al., 2007). Interaction of peptide spots with
MBP- or GST-fused purified proteins was determined by overlaying the
cellulosemembraneswith 10g/ml recombinant protein. Bound recom-
binant proteins were detected with specific primary antisera and a com-
plementary HRP-coupled secondary antibody as for immunoblotting.
For PDE4 arrays, membranes were incubated with translated 35S-labeled
FLAG-tagged fl-DISC1 protein that had been partially purified from 500
l of reticulocyte lysate. Binding of [ 35S]-FLAG-fl-DISC1 was detected
by phosphorimager analysis (Bio-Rad, Hertfordshire, UK).
Metabolic labeling and in vivo phosphorylation of FLAG-DISC1. Cells
transfected with the FLAG-tagged fl-DISC1 cDNA were subdivided into
six-well culture dishes 24 h after transfection and cultured for an addi-
tional day. Cell medium was aspirated, followed by washing in
phosphate-free DMEM (PFDMEM), and incubated overnight with 350
l/well of labeling medium containing PFDMEM, 2% FCS, 20 mM
HEPES, pH 7.4, and 100 Ci of [ 32P]orthophosphate. Cells were then
treated for 15min with vehicle or 100M forskolin/100M IBMX before
harvesting on ice. The labeling medium was discarded, and cells were
washed twice with ice-cold PBS and lysed in immunoprecipitation lysis
buffer supplemented with 10 M okadaic acid. Immunoprecipitated ra-
diolabeled FLAG-tagged fl-DISC1 was visualized by phosphorimager
analysis.
Results
DISC1 has previously been shown to inter-
act with members of the PDE4 family
through their conserved UCR2 domain
(Millar et al., 2005). In SHSY5Y cells, the
endogenous 71 kDa DISC1 isoform binds
PDE4B, which is subsequently released in
a PKA-phosphorylated, activated state in
response to increased cellular cAMP levels
(Millar et al., 2005). Investigation of
DISC1–PDE4 interactions is extended in
the present study by examining interaction
of the fl-DISC1 isoform in immunopuri-





tates with PDE4 isoforms from each of the
fourPDE4 gene families (namely PDE4A5,
PDE4B1, PDE4C2, and PDE4D3) when
these species are cotransfected in HEK293
cells (Fig. 1). This is consistent with our
previous work and the notion that PDE4
isoforms share a common binding site
within DISC1 (Millar et al., 2005).
To evaluate whether these different
PDE4 isoforms could be released from fl-
DISC1 in response to elevated cAMP lev-
els, HEK293 cells were treated with a combination of forskolin
plus the nonspecific phosphodiesterase inhibitor IBMX, to max-
imize cAMP levels within the cells. Intriguingly, although such
treatment had no effect on fl-DISC1 coimmunoprecipitation
with either PDE4A5 or PDE4B1 (Fig. 1A,B), the level of either
PDE4D3 or PDE4C2 associated with fl-DISC1 was markedly re-
duced (Fig. 1C,D). Such results contrast with previous observa-
tions with the 71 kDa DISC1 isoform, where PDE4B was released
in response to increased intracellular cAMP concentrations in
SHSY5Y cells (Millar et al., 2005). Our investigations here, in
which we evaluate fl-DISC1, suggest that PDE4–DISC1 interac-
tions may be more subtle than originally anticipated and seem-
ingly determined by isoform differences in both DISC1 and
PDE4.
We thus set out to examine in more detail the interaction of
both PDE4D3 and PDE4B1 with fl-DISC1 as examples of iso-
forms that respond differentially to elevation of intracellular
cAMP levels.With this inmind, we wanted to determine whether
such differences weremerely specific to these PDE4 isoforms or a
more general feature attributable to these two PDE4 subfamilies.
As with the PDE4B1 long isoform, the PDE4B2 short form and
the PDE4B3 long form both coimmunoprecipitate with fl-DISC1
and are not released after treating cells with forskolin/IBMX to
increase cAMP levels in HEK293 cells (Fig. 2A). In contrast to
this, although the long PDE4D5 isoform also coimmunoprecipi-
tated with fl-DISC1, it, like PDE4D3, was released after treating
cells with forskolin/IBMX to increase cAMP levels (Fig. 2B).
We also investigated these interactions in transfected SHSY5Y
cells as amodel for a neuronal cell environment. In such a system,
we observed that in response to forskolin/IBMX challenge, as in
HEK293 cells, PDE4B1 and fl-DISC1 did not dissociate, whereas
PDE4D3 and fl-DISC1 did dissociate (Fig. 2C). Consistent with
Figure 1. Interaction of the fl-DISC1 isoform with PDE4 isoforms from all four PDE4 gene families. An N-terminally FLAG-
tagged form of the fl-DISC1 isoform (FlagDISC1) was coexpressed in HEK293 cells with PDE4 isoform PDE4A5 (A), PDE4B1 (B),
PDE4C2 (C), or PDE4D3 (D). Cells were challenged with vehicle or 100 M forskolin (Fsk)/100 M IBMX for 15 min before
harvesting. Equalized amounts of cell lysate were immunoprecipitated (IP) with either control IgG or M2 anti-FLAG antibody and
immunoblotted (IB) with PDE4A (A), PDE4B (B), PDE4C (C), or PDE4D (D) antisera (top). Equal immunocapture of FlagDISC1 was
determined by immunoblotting with the anti-FLAG M2 antibody (bottom). The relative expression levels of FlagDISC1 and PDE4
isoforms in5% of total cell lysate input used for coimmunoprecipitation assays were determined by direct immunoblotting
with the PDE4 antisera (top) and the anti-FLAG M2 antibody (bottom).
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these data, generated using exogenously
overexpressed proteins, we also demon-
strated that endogenous 100 kDa PDE4B
complexes isolated from SHSY5Y cells re-
mained stably associated after treatment
with forskolin/IBMX (Fig. 2D).
Probing fl-DISC1 peptide arrays with
PDE4D3 and PDE4B1 fusion proteins
These data suggest that attenuation of fl-
DISC1 interaction with PDE4 isoforms by
increased cAMP levels is PDE4 subfamily
dependent and therefore likely involves
distinct interaction sites. Spot-
immobilized peptide array analysis has
proved to be a powerful novel technology
to gain insight into putative interaction
sites underpinning protein–protein inter-
action. Indeed, we have recently exploited
this technique to identify interaction sites
that define the interaction of the PDE4D5
isoform with the signaling scaffold pro-
teins arrestin and RACK1 (Bolger et al.,
2006; Baillie et al., 2007) and between
PDE4D3 and the PKA scaffold AKAP18
(Stefan et al., 2007). Taking PDE4D3 and
PDE4B1, which are both expressed in
brain (Engels et al., 1995; Bolger et al.,
1997; Thompson et al., 2000; Miro et al.,
2002; Richter et al., 2005), as paradigms
for classes of PDE4 isoforms that show
profound differences in susceptibility to
release from fl-DISC1 after elevation of in-
tracellular cAMP,we set out to seewhether
they showed differences in interaction
with a scanning peptide array of fl-DISC1.
In this strategy, a library of overlapping
peptides (25-mers), sequentially shifted by
5 aa across the entire sequence of fl-DISC1,
was immobilized on cellulose membranes.
This was then probed with either MBP-
PDE4B1 or MBP-PDE4D3, which are re-
combinant fusion proteins of PDE4B1 and
PDE4D3, respectively, made with MBP
and expressed in E. coli before purification for use as probes. Here
we show portions of typical arrays in which positive interactions
are evident as dark spots on the array (Fig. 3A,B). Both of the
probes identified two interaction sites on the fl-DISC1 arrays,
corresponding to amino acids 190–230 [PDE4 common site 1
(cs1)] and 611–650 (PDE4 cs2) in fl-DISC1 (Fig. 3A,C), indicat-
ing that they are likely to provide common sites of interaction for
these PDE4 isoforms. In this regard, previous studies (Millar et
al., 2005), using truncated DISC1 constructs, had identified a
region overlapping with PDE4 cs1 (Fig. 3C) as of importance in
PDE4B binding. Additionally, however, we show here that the
PDE4B1 probe, but not the PDE4D3 probe, interacted with three
additional regions on the fl-DISC1 peptide array (Fig. 3B,C) cor-
responding to residues 31–65 [PDE4B specific site 1 (4bss1)],
101–135 (4bss2), and 266–290 (4bss3). These additional interac-
tion sites on the fl-DISC1 array were also detected using a
PDE4B2 probe (GST-PDE4B2), indicating that interaction was
PDE4B subfamily specific (Fig. 3D).
We set out to confirm independently that PDE4B isoforms
interact with both the N- and C-terminal regions of DISC1 using
truncated forms of fl-DISC1. Thus, both a GST-DISC1 (amino
acids 220–283) fusion protein that encompasses the PDE4 cs1
and 4bss3 binding sites as well as a GST-DISC1 (amino acids
359–854) fusion protein encompassing the PDE4 cs2 (Fig. 3E)
were able to bind to PDE4B when coexpressed in transfected
HEK293 cells (Fig. 3E).
Very recently, novel pointmutations in themurineDisc1 gene
have been identified that confer behavioral, brain structural, and
pharmacological phenotypes related to schizophrenia and de-
pression (Clapcote et al., 2007). These are predicted to cause,
individually, Gln31Leu and Leu100Pro mutations in murine
Disc1. Intriguingly, such mutations are located within regions
that we have implicated here as being involved specifically in
PDE4B association with DISC1, namely 4bss1 and 4bss2, respec-
tively (Fig. 3C). Because sequences surrounding Gln31 and
Leu100 in murine Disc1 are not highly conserved in human
DISC1 (Clapcote et al., 2007), we used peptide Spot arrays to
determine whether PDE4B would interact with peptides that in-
Figure 2. PDE4B isoforms remain stably associated with the fl-DISC1 isoform; DISC1 interaction with members of the PDE4D
subfamily are disrupted by treatment with forskolin/IBMX. A, HEK293 cells were cotransfected to express Flag-tagged fl-DISC1
and PDE4B isoforms PDE4B1, PDE4B2, and PDE4B3. Cells were challenged by treatmentwith vehicle or 100M forskolin/100M
IBMX for 15 min. Equal amounts of cell lysate were subjected to anti-FLAG M2 immunoprecipitation. The coprecipitation of
PDE4B1, PDEB2, or PDEB3 with FlagDISC1 was detected using the PDE4B antibody (top). Equalized FlagDISC1 expression was
confirmed by immunoblottingwith the anti-FLAGM2 antibody (bottom).B, HEK293 cells coexpressing Flag-tagged fl-DISC1 and
PDE4D isoforms PDE4D3 andPDE4D5were challengedwith vehicle or 100M forskolin/100M IBMX for 15min. Cell lysateswere
immunoprecipitated with the PDE4D antibody. Coprecipitated FlagDISC1 was visualized using the anti-FLAG M2 antibody (top).
The relative expression levels of FlagDISC1 and the PDE4D isoforms in cell lysates were determined by immunoblotting with the
anti-FLAG M2 (middle) and PDE4D (bottom) antibodies. C, SHSY5Y neuroblastoma cells were cotransfected with Flag-tagged
fl-DISC1 and either PDE4B1 or PDE4D3. Cells were treated with or without 100 M forskolin/100 M IBMX for 15 min before
preparation of cell lysates. Anti-FLAG immunoprecipitation was performed to isolate DISC1 protein complexes. The amount of
PDE4B1 and PDE4D3 present in FlagDISC1 immunoprecipitates (top) and expression in cell lysates (bottom) was determined by
immunoblotting with the PDE4B and PDE4D antibodies, respectively. D, SHSY5Y cells were treated with or without 100 M
forskolin/100M IBMX for 15 min before preparation of cell lysates. Anti-PDE4B immunoprecipitation was performed to isolate
endogenousPDE4B–DISC1 complexes. The amount of PDE4B (bottom) andDISC1 (top) present in PDE4B immunoprecipitateswas
determined by immunoblotting. An antibody that specifically recognizes the 100 kDa fl-DISC1 isoform was used (Ogawa et al.,
2005). Fsk, Forskolin; IP, immunoprecipitated; IB, immunoblotted.
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cluded these sites of mutation in murine
Disc1. Indeed, we show here that the MBP
fusion protein of PDE4B1 interacted with
each of themurine Disc1 peptides that, re-
spectively, both encompass these muta-
tions and the cognate human sequence of
which is located in either 4bss1 or 4bss2
sites (Fig. 3F). Furthermore, we clearly ob-
served a diminished interaction with the
Leu100-containing peptide when this sin-
gle residue was substituted with either
Leu100Ala or Leu100P (Fig. 3F,G), the
latter mutation leading to reduced
PDE4B1/Disc1 association inmutantmice
(Clapcote et al., 2007). In contrast,
Gln31Ala and Gln31Leu substitutions,
found in mutant mice (Clapcote et al.,
2007), did not reduce the interaction with
themurine peptide that reflected sequence
at the 4bss1 site (Fig. 3F). This suggests
that mutation at such a site likely exerts its
effect by altering the conformation of
Disc1, thereby indirectly affecting interac-
tion with PDE4B.
Probing fl-DISC1 peptide arrays with
UCR1, UCR2, and the PDE4D CAT unit
Individual PDE4 isoforms differ by virtue
of their extreme N-terminal regions, with
the common regions being provided by
UCR1, UCR2, and the CAT unit.
N-terminal truncation studies have previ-
ously implicated UCR2 as of importance
in the interaction of PDE4B with DISC1
(Millar et al., 2005). Here we have sug-
gested that PDE4B and PDE4D likely con-
tain similar binding sites able to bind to
common sites on fl-DISC1, which may be
represented by PDE4 cs1 and PDE4 cs2
(Fig. 3C), whereas PDE4B likely contains
additional binding sites able to interact
with the regions encompassed by 4bss1–3
(Fig. 3C) on fl-DISC1. To gain insight into
which regions of PDE4D were involved in
interacting with fl-DISC1, we probed the
fl-DISC1 array with recombinant GST fu-
Figure 3. Probing DISC1 peptide arrays for PDE4B and PDE4D interaction sites. A, B, An array of immobilized peptide spots of
overlapping 25-mer peptides, each shifted along by 5 aa in the entire sequence of the fl-DISC1 isoform,was probed for interaction
withMBP fusion proteins of PDE4B1 (MBP-4B1) or PDE4D3 (MBP-4D3) orMBP alone and detected by immunoblotting. Dark spots
were evidence of positive interaction, whereas noninteracting peptides left white (blank) spots. In all other sections of the array,
spots were blank with the probes. Spot numbers relate to the 25-mer peptides in the array with the amino acid sequence of the
peptide spots given below the array data. C, Schematic of DISC1 and PDE4 protein structure. DISC1 comprises an N-terminal
globular domainwithpredicted coiled-coil (CC) regionswithin its C-terminal domain. LongPDE4 isoforms consist of twoupstream
conserved regions (UCR1 and UCR2) linked to the CAT subunit by linker regions. Distinct PDE4 isoforms are characterized by a
unique N-terminal region. The sites of DISC1–PDE4 interaction established from peptide array analyses are highlighted (cs,
common PDE4 binding site; 4bss, PDE4B-specific binding site). The relative position of mutations in mouse Disc1 that confer
phenotypes related to psychiatric illness are indicated, namely Q31L and L100P D, DISC1 peptide arrays were probed with either
MBP-4B1 or a GST fusion protein of PDE4B2 (GST-4B2), and interaction was detected by immunoblotting. Positively interacting
peptide spots are shownwith the related DISC1 regions given. E, HEK293 cells were transfectedwith the indicated pEBG-2T DISC1
plasmids and FLAG-tagged PDE4B3. Lysates were incubated with glutathione–Sepharose beads to capture GST or GST–fl-DISC1
complexes and immunoblotted with the anti-GST antibody to detect fl-DISC1 fusion proteins (data not shown) or anti-FLAG M2
antibody to detect the presence of coprecipitated PDE4B3. F, An MBP fusion protein of PDE4B1 was used to probe peptides
reflecting the murine Disc1 sequence, namely one containing Gln31 (Q31), GHGLPPAVAPQ(31)RRRLTRRPGYMRST (left) and one
containing Leu100 (L100), SHCQASLVGKPFL(100)KSSLVPAVASEG (right). In addition the indicatedmutant peptides were probed
to assess PDE4B1 binding to Leu100Ala, Leu100Pro, Gln31Ala, and Gln31Leu. G, Densitometric analysis of MBP–PDE4B1 interac-
tion with the wild-type and indicated mutant forms of the Leu100 SHCOASLVGKPFL(100)KSSLVPAVASEG peptide. H, GST fusion
proteins of individual PDE4D domains, UCR1, UCR2, and CAT were used to probe fl-DISC1 peptide arrays and binding of probes
detected by immunoblottingwith the anti-GST antibody. The interactions of the PDE4D probes with fl-DISC1 peptide spots of the
common PDE4 binding sites (as determined in Fig. 4A) are shown. I, HEK293 cells coexpressing Flag-tagged fl-DISC1 and PDE4D3
were incubated for 2–3hwith50MstearoylatedDISC1peptides ofDISC1 regions encompassing cs1 (CS1P, SHSAFTSSFSFIRLSLG-
SAGERGE) and cs2 (CS2P, IRSLTSEREGLEGLLSKLLVLSSRN). Cells were then harvested, and lysates were immunoprecipitated with
PDE4D antisera. Coprecipitation of FlagDISC1 was assessed by immunoblotting with the anti-FLAG M2 antibody (top). Equal
immunocapture of PDE4D3 was determined by immunoblotting immunoprecipitates with the PDE4D antibody (middle). The
4
relative expression level of FlagDISC1 in 5% of total cell
lysate input used for coimmunoprecipitation assays was de-
termined by direct immunoblotting with the anti-FLAG M2
antibody (bottom). J, As in I, cells coexpressing Flag-tagged
fl-DISC1 and PDE4B1were incubatedwith stearoylated DISC1
peptides CS1P and CS2P. Cell lysates were then incubated
with PDE4B antisera, and PDE4B immunoprecipitates were
immunoblottedwith anti-FLAGM2 antibody to detect copre-
cipitated FlagDISC1 (top). Immunocapture of PDE4B1 was
confirmed by immunoblotting immunoprecipitates with
PDE4B antisera (middle). Equivalent input expression of Flag-
DISC1 was determined by immunoblotting5% of total cell
lysate used for the coimmunoprecipitation assays with the
anti-FLAGM2antibody (bottom). IP, Immunoprecipitated; IB,
immunoblotted.
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sion proteins of either UCR1 or UCR2 or
the full-length CAT unit of PDE4D. No
positive binding spots were detected with
GST-UCR1 overlay, whereas with GST-
UCR2, positive (dark) spots were evident
in peptides of the first common binding
region, cs1 (Fig. 3H). These data are con-
sistent with previous N-terminal trunca-
tion studies implying that UCR2, and not
UCR1, played a role in the binding of
PDE4B1 to DISC1 (Millar et al., 2005).
This is also consistent with studies using
full-length MBP-PDE4D3 and MBP-
PDE4B1 as probes (Fig. 3A,B), which each
identified PDE4 cs1 (Fig. 3C) as a possible
(common) interaction region in fl-DISC1.
This is, presumably, attributable to an in-
teraction involving the common 80 aa
UCR2 that is highly conserved (93%) be-
tween PDE4D and PDE4B (Conti et al.,
2003; Houslay and Adams, 2003; Houslay
et al., 2005).
The PDE4D CAT unit fusion protein
identified the second common interaction
site, PDE4 cs2 (Fig. 3C,H), suggesting that
UCR2 and the CAT unit provide the
sources of interaction with two PDE4 sub-
family common interaction sites in fl-
DISC1. Notwithstanding this, the GST-
CAT fusion protein also appeared to
interact with peptide spots representing
the PDE4 cs1 region (Fig. 3C,H). A possi-
ble reason for this is an intriguing shared
motif of the form-Ser-X2--X2-Ser-Ser-
X2--X-(Lys/Arg)-Leu-X0/1-Ser--X5-
Arg, observable within both cs1 and cs2 (
is a hydrophobic amino acid).
These data imply that PDE4D3 inter-
acts with fl-DISC1 only through cs1 and
cs2, whereas PDE4B1 interaction with fl-DISC1 involves addi-
tional binding sites. We thus set out to determine whether the
binding of PDE4D3 could be disrupted in cells using peptides
that represent the common core cs1 and cs2 regions and thus
would be expected to compete with fl-DISC1 for sequestering
PDE4D3. Stearoylated peptides have been shown to enter cells,
and specific species have been used to disrupt protein–protein
complexes by competing for binding partners (Hundsrucker et
al., 2006). Thus, we treated cells transfected to express both fl-
DISC1 and PDE4D3 with either or both peptide CS1P (DISC1
residues 201-SHSAFTSSFSFIRLSLGSAGERGE-224), which re-
flects the cs1 region, and peptide CS2P (DISC1 residues 611-
IRSLTSEREGLEGLLSKLLVLSSRN-635), which reflects the cs2
region to compete for PDE4 interaction at these common core
sites in fl-DISC1. Here we see that treatment with either CS1P or
CS2P peptide alone had no effect on PDE4D3–fl-DISC1 interac-
tion, as evidenced from coimmunoprecipitation studies, when
cells were treated with both peptides together and then PDE4D3
interaction with fl-DISC1 was abolished (Fig. 3I). In marked
contrast to this, exposure to CS1P or CS2P peptides either alone
or together failed to disrupt PDE4B1–fl-DISC1 interaction (Fig.
3J), consistent with additional sites being involved in PDE4B1–
fl-DISC1 interaction.
Probing PDE4D and PDE4B peptide arrays with fl-DISC1
We set out now to perform the converse experiments probing
PDE4D andPDE4Bpeptide arrays with fl-DISC1.Unfortunately,
as with others previously, despite much effort with different
growth conditions and constructs, we were singularly unsuccess-
ful in generating fl-DISC1 as a soluble protein able to be purified
from E. coliwhen expressed as a GST fusion protein. To generate
a useful probe, we therefore expressed fl-DISC1 as a radiolabeled
species using an in vitro transcription–translation system in
which [35S]methionine was incorporated into the protein. We
have used a similar strategy previously to generate [35S]-labeled
PDE4A1 for various binding studies (Smith et al., 1996; Baillie et
al., 2002). Using a cDNA encoding fl-DISC1 as a template, we
identified a single radiolabeled protein product of the expected
size (100 kDa) in extracts analyzed on SDS-PAGE (data not
shown). This product was used for overlays of PDE4 peptide
arrays, with detection by phosphorimager analysis.
Analysis of PDE4B and PDE4D arrays revealed DISC1 inter-
acted with two common regions that corresponded, respectively,
to residues within the UCR2 domain (Fig. 4A,B) and CAT unit
(Fig. 4D,E). Alignment between the UCR2 domains of PDE4D
and PDE4B show an overall 90% sequence identity (supplemen-
tal Fig. 1, available at www.jneurosci.org as supplemental mate-
rial), whereas the CAT unit sequences of PDE4D and PDE4B
Figure 4. Probing PDE4B and PDE4D peptide arrays for fl-DISC1 interaction sites: PDE4 subfamilies exhibit common regions of
DISC1 binding. A, B, D, E, Peptide arrays of the PDE4B (A, D) and PDE4D (B, E) sequences were probed with partially purified
[ 35S]-labeled fl-DISC1protein, andbinding topeptide spotswasdetectedbyphosphorimager analysis.C,F, Sites common toboth
PDE4B and PDE4D for fl-DISC1 interaction are shown with the sequence homology between PDE4B and PDE4D at these binding
regions highlighted.
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show an overall 85% identity (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material). Comparative se-
quence analysis shows that each of the fl-DISC1 binding regions
is highly conserved between PDE4B and PDE4D (Fig. 4C,F).
In addition to these two common regions, radiolabeled fl-
DISC1 bound to a region specific to the PDE4B CAT unit (Fig.
5A,B) and, intriguingly, one specific for the PDE4D CAT unit
(Fig. 5D,E). Alignment of PDE4B and PDE4D sequences within
these regions highlight significant disparities in the primary
structure (Fig. 5C,F).
N-terminal truncation of DISC1 allows cAMP-mediated
release of PDE4B1
Increased cAMP levels cause the release of PDE4D3, but not
PDE4B1, from fl-DISC1. Our peptide array analyses indicate that
the N-terminal portion of fl-DISC1 contains three potential sites
involved in facilitating PDE4B, but not PDE4D, interaction. We
hypothesize that elevated cAMP levels disrupt PDE4 interaction
at the common binding sites on DISC1 and that PDE4B is pro-
tected from release as it also interacts with additional binding
sites on fl-DISC1 that are containedwithin its N-terminal region.
To explore this, we generated a truncate of fl-DISC1that lacks the
first 187 N-terminal amino acids (1–187-fl-DISC1) and that re-
moves twoof the threeputativePDE4B-uniquebinding regions.We
show here that this construct still binds PDE4B1, but now, as with
PDE4D3, it is released during elevation of
intracellular cAMP levels (Fig. 6).
PKA action is required for the release of
PDE4D3 from fl-DISC1
The cellular phenotypes consequent after
cAMP elevation are transduced through
the activation of either PKA (Tasken and
Aandahl, 2004) or EPAC (Bos, 2006), a
guanine-nucleotide exchange protein that
is directly activated by cAMP. Here we
show that coimmunoprecipitation of
PDE4D3 with fl-DISC1 was unaffected
when either untransfected cells or those
transfected to allow for exogenous EPAC1
expression were treated with EPAC ago-
nist (Fig. 7A). Activation of EPAC1 was
confirmed by confocal imaging of cells im-
munostained with antisera raised specifi-
cally against the cAMP-activated form of
EPAC1 (data not shown). In contrast, co-
immunoprecipitation of PDE4D3 with fl-
DISC1 was markedly attenuated after for-
skolin/IBMX treatment (Figs. 1D, 7A).
These data indicate a role for PKA rather
than EPAC in underpinning PDE4D3 re-
lease fromfl-DISC1.Consistentwith suchan
involvement of PKA, the action of forskolin/
IBMXwas attenuated after expression of the
PKA inhibitory peptide PKI (Fig. 7B).
Because learning and memory path-
ways and defects in schizophrenia can in-
volve the ERK signaling pathway (Kyo-
sseva, 2004; Sweatt, 2004) as well as that
directed by cAMP, we set out to determine
whether ERK activation, which occurs
consequent after EGF challenge of these
cells, might alter the association of
PDE4D3 with fl-DISC1. However, activation of ERK during
stimulation with EGF failed to dissociate DISC1–PDE4D3 com-
plexes (Fig. 7C). Immunoblotting of cell lysates with phospho-
Erk1/2 antisera confirmed the activation of the Erk signaling
pathway in these cells after EGF challenge (Fig. 7C).
PKA phosphorylation of PDE4D3 is not required for
attenuation of PDE4D3 interaction with fl-DISC1
Activation of PKA by increased cAMP levels causes the phos-
phorylation of long isoforms from all four PDE4 subfamilies at a
conserved site within UCR1, leading to their activation (Sette et
al., 1994; Sette and Conti, 1996; Hoffmann et al., 1998; MacKen-
zie et al., 2002). In the case of PDE4D3, such stimulatory phos-
phorylation occurs at Ser54 within the PKA consensus motif
RRES. We thus used mutants at Ser54 to evaluate whether phos-
phorylation at this site was involved in the cAMP-dependant
attenuation of fl-DISC1–PDE4D3 interaction. Here we see that
the Ser54Ala mutant of PDE4D3, which can no longer be phos-
phorylated at this site as shown previously (Sette et al., 1994; Sette
and Conti, 1996; Hoffmann et al., 1998; MacKenzie et al., 2002),
is still released after elevating cAMP levels by forskolin/IBMX
challenge (Fig. 8A). The Ser54Asp mutant has previously been
shown tomimic the stimulatory effect of PKAphosphorylation at
this site in PDE4D3. However, the Ser54Asp-PDE4D3 mutant
Figure 5. Probing PDE4B and PDE4D peptide arrays for DISC1 interaction sites: PDE4B- and PDE4D-specific sites of DISC1
binding. A, B, D, E, As in Figure 4, PDE4B (A, E) and PDE4D (B, D) peptide arrays were probed with [ 35S]-fl-DISC1. C, F, Sites of
[ 35S]-DISC1 binding unique to PDE4B or PDE4D are shownwith comparative PDE4B and PDE4D sequence alignment at these sites
highlighted.
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not only was still capable of binding to fl-DISC1 but was also
released after challenge of cells with forskolin/IBMX (Fig. 8A).
PDE4D3 is unusual among long PDE4 isoforms in that its
unique N-terminal region has an additional site for phosphory-
lation by PKA, namely Ser13. Phosphorylation at this site has no
effect on PKA activity but has been shown to increase the ability
of PDE4D3 to bind to mAKAP (Dodge et al., 2001; Carlisle
Michel et al., 2004), a PKA scaffolding protein found exclusively in
cardiacmyocytes and that is upregulated in hypertrophy. A double-
mutantconstruct inwhich theSer13andSer54PKAsites inPDE4D3
were ablated by alanine mutation (Ser13Ala:Ser54Ala) had no dis-
cernible effect on PDE4D3 interaction with fl-DISC1, and neither
did it abrogate the ability of forskolin/IBMX to attenuate the inter-
action of PDE4D3 with fl-DISC1 (Fig. 8B).
We also generated an N-terminally truncated form of
PDE4D3 so as to delete its unique N-terminal region, UCR1 and
UCR2, which removes both of the phosphorylation sites for PKA.
This construct lacks the UCR2 interaction site for fl-DISC1 but
contains the putative fl-DISC1 interaction sites within the CAT
unit. Interestingly, this species was both able to coimmunopre-
cipitate with fl-DISC1 but was also released from DISC1 in cells
subject to forskolin/IBMX challenge (Fig. 8C).
Challenge with forskolin/IBMX does not elicit
fl-DISC1 phosphorylation
Although fl-DISC1 is phosphorylated in resting cells where PKA
is inactive, there is no increase in fl-DISC1 phosphorylation sub-
sequent to challenge with forskolin/IBMX, and the fl-DISC1
phosphorylation status was unaffected by PKA inhibition with
PKI (Fig. 9A). The canonical consensus motif for authentic PKA
substrates in vivo is Arg-Arg-X-Ser-Xhydrophobic, although in some
instances, weaker substrates are found where Thr substitutes for
Ser and Lys substitutes for Arg. The nearest to such a motif in the
sequence of fl-DISC1, which can be identified either manually or
by Scansite (http://scansite.mit.edu/) analysis, is at Thr744.How-
ever, at best, Thr744 might provide a weak putative PKA phos-
phorylation because it lies within the sequence Lys-Arg-Lys-Thr-
Pro. As a PKA site, it will be compromised by having a side chain-
distorting proline next to the target phosphorylation site, a
positively charged lysine adjacent to the target phosphorylation
site, a Thr rather than a Ser as the target phosphorylation site, and
a Lys-Arg rather than Arg-Arg at positions2 and3 from the
target phosphorylation site. This is consistent, then, with our
inability to observe increased phosphorylation of fl-DISC1 in
intact cells challenged with forskolin/IBMX (Fig. 9A).
Figure 6. N-terminal truncation of fl-DISC1 sensitizes PDE4B1 to cAMP-mediated release.
HEK293 cells cotransfected with PDE4B1 and either myc-HIS-tagged fl-DISC1 or myc-HIS-
tagged DISC1 N-terminal truncate lacking residues 1–187were treatedwith vehicle or 100M
forskolin/100M IBMX for 15min before harvesting and immunoprecipitationwith the PDE4B
antibody. Coprecipitated myc-HIS-DISC1 species were detected with the anti-myc 9E10 anti-
body (top). Successful immunocapture of PDE4B1 was demonstrated with the PDE4B antibody
(bottom). The input signal shows the expression levels of PDE4B1 (bottom) andmyc-HIS DISC1
proteins (top) as determined by direct immunoblotting of5% total cell lysate used for im-
munoprecipitation assays. IP, Immunoprecipitated; IB, immunoblotted.
Figure 7. Activation of PKA mediates PDE4D3 release from the fl-DISC1 isoform. A, HEK293
cells exogenously expressing Flag-tagged fl-DISC1, PDE4D3 and EPAC1 were challenged with
either vehicle, 100M forskolin/100M IBMXor EPACagonist (8-pCPT-2-O-Me-cAMP,10M)
for 15 min. FlagDISC1 complexes were isolated from cell lysates by immunoprecipitation with
the anti-FLAGM2 antibody, and the PDE4D antibodywas used to detect coprecipitated PDE4D3
(top). Equalized capture of FlagDISC1 in immunoprecipitates was determined with the anti-
FLAG M2 antibody (bottom). The input signals show relative levels of FlagDISC1 (top) and
PDE4D3 (bottom) expression in5% of the total cell lysate used for immunoprecipitation
experiments. Cellular activation of EPAC1was visualized by immunofluorescent staining of cells
with antisera specific for the detection of cAMP-activated EPAC1. Confocal imaging of cells
immunostained with the cAMP-activated EPAC1 antibody are shown. B, HEK293 cells were
transfected to express either Flag-tagged fl-DISC1, PDE4D3, and empty vector or Flag-tagged
fl-DISC1, PDE4D3, and PKI. Cells were then treated with or without 100M forskolin/100M
IBMX for 15 min. After harvesting, equal amounts of cell lysate were incubated with the anti-
FLAGM2 antibody to isolate FlagDISC1 complexes. FlagDISC1 immunoprecipitateswere immu-
noblotted with the PDE4D (top) and anti-FLAG M2 (bottom) antibodies. Relative expression of
PDE4D3 and FlagDISC1 in 5% of cell lysate input for immunoprecipitation experiments is
shown in the top and bottom panels, respectively. The cells imaged in A, as determined by
bright-field microscopy, are shown. C, HEK293 cells coexpressing Flag-tagged fl-DISC1 and
PDE4D3 were treated with vehicle, 100 M forskolin/100 M IBMX, or 200 ng/ml EGF for 15
min. FlagDISC1 complexes were immunopurified with the anti-FLAG M2 antibody, and the
PDE4D antibody was used to detect coprecipitated PDE4D3 (top). Equalized capture of Flag-
DISC1 in immunoprecipitates was determined with the anti-FLAG M2 antibody (bottom). The
input signals show relative levels of FlagDISC1 (top) and PDE4D3 (bottom) expression in5%
of the total cell lysate used for immunoprecipitation experiments. EGF-mediated Erk activation
was confirmed by immunoblotting of cell lysates with phospho-Erk1/2 antisera (top right). IP,
Immunoprecipitated; IB, immunoblotted.
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Nevertheless, to negate any possibility that PKA might phos-
phorylate fl-DISC1 at Thr744 in these cells, we generated a
FLAG-tagged version of fl-DISC1 with a Thr744Ala mutation.
Using such a construct, we were able to find that not only could it
coimmunoprecipitate with PDE4D3 but that PDE4D3 was re-
leased from such a mutant form of fl-DISC1 when transfected
cells were challenged with forskolin/IBMX (Fig. 9B).
Discussion
cAMP and the control of its degradation by PDEs, including
PDE4, has a well appreciated role in regulating learning and
memory processes (Barad et al., 1998; O’Donnell and Zhang,
2004; Arnsten et al., 2005; Blokland et al., 2006). Recently, we
have shown that DISC1 interacts with PDE4B (Millar et al., 2005;
Cheung et al., 2007). This is likely to be of importance because
PDE4 recruitment to signaling protein complexes confers spatial
and temporal regulation of localized cAMP levels (Baillie et al.,
2005). fl-DISC1 interacts with members from all four PDE4 sub-
families (Fig. 1), implying the presence of a conserved binding
site(s). However, profound functional differences between PDE4
4
M2antibodywas used to immunoprecipitate FlagDISC1, and coprecipitating CATwas visualized
by immunoblotting with the PDE4D antibody (top). Equalized expression of CAT and FlagDISC1
in input lysates for immunoprecipitation assays was verified by immunoblotting with the
PDE4D (top) and anti-FLAGM2 (bottom) antibodies. IP, Immunoprecipitated; IB, immunoblot-
ted; WT, wild type.
Figure 8. PKA phosphorylation of PDE4D3 is not responsible for PKA-induced dissociation of
PDE4D3 from the fl-DISC1 isoform.A, HEK293 cells cotransfectedwith Flag-tagged fl-DISC1 and
eitherwild-typePDE4D3orPDE4D3mutants S54Aor S54Dwere challengedwithorwithout 100
M forskolin/100M IBMX. Equal amounts of cell lysate were used to prepare anti-FLAG M2
immunoprecipitates, and coprecipitated PDE4D3 was detected by immunoblotting with the
PDE4D antibody (top). Equalized expression of PDE4D3 and FlagDISC1 in input lysates for im-
munoprecipitation assays was verified by immunoblotting with the PDE4D (middle) and anti-
FLAG M2 (bottom) antibodies. B, Similar to above, HEK293 cells coexpressing Flag-tagged
fl-DISC1 with either wild-type PDE4D3 or PDE4D3 S13A:S54A mutant were treated with or
without forskolin/IBMX for 15 min. Cell lysates were then subjected to anti-FLAGM2 immuno-
precipitation, and the coprecipitated PDE4D3 was detected with the PDE4D antibody (top).
Relative expression inputs of PDE4D3 and FlagDISC1 are shown in the middle and bottom
panels, respectively. C, HEK293 cells were cotransfected with Flag-tagged fl-DISC1 and PDE4D
CAT domain and treated with vehicle or 100M forskolin/100M IBMX for 15 min. Anti-FLAG
Figure9. cAMP-induced PKA activation does not elicit PKAphosphorylation of DISC1 in vivo.
Attenuation of DISC1:PDE4D3 interaction is not mediated through PKA phosphorylation of
DISC1. A, COS1 cells coexpressing Flag-tagged fl-DISC1 plus empty vector or Flag-tagged fl-
DISC1 plus PKI were metabolically labeled with [ 32P]orthophosphate and challenged with ve-
hicle or 100 M forskolin/100 M IBMX before harvesting. Equivalent amounts of cell lysate
were incubated with anti-FLAGM2 antibody to immunoprecipitate Flag-tagged DISC1. Immu-
noprecipitates were resolved by SDS-PAGE, and radiolabeled Flag-tagged DISC1was visualized
by autoradiography. B, HEK293 cells coexpressing PDE4D3 with either Flag-tagged fl-DISC1 or
the Flag-tagged-fl-DISC1 T744A mutant were treated with either vehicle or 100M forskolin/
100 M IBMX for 15 min. Equalized cell lysates were incubated with the PDE4D antibody to
precipitatePDE4D3, and coprecipitatedFlagDISC1wasdeterminedby immunoblottingwith the
anti-FLAG M2 antibody (top). Immunocapture of PDE4D3 in immunoprecipitates was con-
firmed with the PDE4D antibody (bottom). Relative expression of Flag-tagged DISC1 and
PDE4D3 in 5% of cell lysate input for immunoprecipitation experiments is shown in the top
and bottom panels, respectively. Ctr, Control; IP, immunoprecipitated; IB, immunoblotted.
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subfamilies were evident because elevating intracellular cAMP
levels caused release of PDE4C and PDE4D but not PDE4A and
PDE4B (Figs. 1, 2). This contrasts with previous studies identify-
ing PDE4B as a novel binding partner for the 71 kDa DISC1
isoform in SHSY5Y neuroblastoma cells that is released when
intracellular cAMP levels increase (Millar et al., 2005). In contrast
to fl-DISC1, the exact nature of the short 71 kDa DISC1 isoform
is unknown. Thus, DISC1–PDE4 interactions are more complex
than previously envisaged, with factors such as DISC1 and PDE4
isoform expression being defining criteria.
To gain insight into fl-DISC1/PDE4 binding regions, we used
a novel peptide array strategy, which we have used to identify
PDE4 binding sites on the scaffold proteins arrestin, RACK1,
and AKAP18 (Bolger et al., 2006; Baillie et al., 2007; Stefan et al.,
2007). Here we focused on PDE4B and PDE4D as examples of
subfamilies that bind fl-DISC1 but differ in their sensitivity to
dissociation by elevated intracellular cAMP. Using fl-DISC1 ar-
rays, we identified two binding sites common to PDE4B and
PDE4D, one (cs1) located between amino acids 191–230 of fl-
DISC1 and one (cs2) located within a predicted C-terminal
coiled-coil domain (amino acids 611–650) (Fig. 3C). Indeed,
various proteins that sequester PDE4 use multiple binding sites
(MacKenzie et al., 2000; Bolger et al., 2006; Baillie et al., 2007).
N-terminal truncation, leading to removal of cs1 as well as
PDE4B-specific sites, abrogated PDE4B1 interaction with fl-
DISC1 (Millar et al., 2005), implying that multiple sites are re-
quired for complex stabilization in vivo.
UCR2, which is conserved through PDE4 subfamilies, was
suggested as interacting with fl-DISC1 (Millar et al., 2005), im-
plying that UCR2 binds a common site on fl-DISC1. Consistent
with this, probing fl-DISC1 arrays with UCR2 (Fig. 3H) demon-
strated interaction with cs1 only (Fig. 3C).
The cs2 site in fl-DISC1 (Fig. 3C) should interact with a con-
served region of PDE4. Indeed, probing fl-DISC1 arrays with the
PDE4D CAT unit identified the cs2 site (Fig. 3H). Surprisingly,
this probe also identified cs1 (Fig. 3H). However, both cs1 and
cs2 share a motif (vide supra) that may allow the PDE4 CAT unit
to bind each region in vitro. Indeed, the presence of both cs1 and
cs2 in fl-DISC1 is likely to ensure fidelity of UCR2 association
with cs1 and of the PDE4 CAT unit with cs2, because this will
maximize PDE4/fl-DISC1 contact.
While probing fl-DISC1 arrays with PDE4D3 identified only
cs1 andcs2 sites, probingwithPDE4B1 identifiedadditionalbinding
sites located within the fl-DISC1 N-terminal region (Fig. 3) pre-
sumed as either missing or altered in short DISC1 isoforms. Such
PDE4B-specific binding sites on fl-DISC1may protect the complex
from dissociation when intracellular cAMP levels are elevated.
Consistent with the above analyses, performing reciprocal
studies, when PDE4B and PDE4D peptide arrays were probed
with fl-DISC1, we identified two common sites of interaction:
one within UCR2 (Fig. 4C) and the other within a highly con-
served region of the CAT unit (Fig. 4F).
Array analyses also indicated a site for fl-DISC1 interaction
that was unique to PDE4B and located within a partially con-
served region of theCATunit (Fig. 5A–C). Thismay interact with
the PDE4B-specific binding sites on fl-DISC1. We also identified
a putative binding site for fl-DISC1unique to PDE4Dand located
within a region of its CAT unit that has significant sequence
disparity to the equivalent PDE4B region (Fig. 5F). However,
PDE4D appears to interact only with the cs1 and cs2 sites in the
fl-DISC1 peptide array. Thus, either folded fl-DISC1 is required
to interact with this PDE4D specific binding site or, while ex-
posed in the peptide array, it remains cryptic in the folded
PDE4D. Notwithstanding this, we show here that cell-permeable
peptides reflecting cs1 and cs2 of DISC1 suffice to disrupt inter-
action of fl-DISC1 in cells with PDE4D3, but not PDE4B1 (Fig.
3 I, J). This supports the contention that fl-DISC1 sequesters
PDE4D3 through cs1/cs2 and that PDE4B1 interaction involves
additional sites (Fig. 3C).
Disruption of fl-DISC1–PDE4D3 complexes occurs during
PKA activation (Figs. 1, 2). This is not attributable to PKA phos-
phorylation of PDE4D3 because complex dissociation during
PKA activation was not ablated after Ala mutagenesis (Fig. 8) of
either of the two PKA sites in PDE4D3, Ser54 or Ser13 (Sette and
Conti, 1996; MacKenzie et al., 2002). fl-DISC1 is a phosphopro-
tein (Fig. 9A), although the identity of the phosphorylation site(s)
is unknown. Basal phosphorylation is not attributable to PKA
because it was unaffected by expression of the PKA inhibitor PKI
(Fig. 9A). Furthermore, fl-DISC1 phosphorylation was not in-
creased after forskolin/IBMX challenge, which activates PKA in
these cells (Lynch et al., 2005; Baillie et al., 2007). Indeed, se-
quence analysis reveals that there is no obvious PKA phosphory-
lation consensus motif. The closest sequence that can be identi-
fied, either manually or by Scansite (http://scansite.mit.edu/)
analysis, is at Thr744. This, at best, might provide a weak site for
PKA phosphorylation, lying within the sequence Lys-Arg-Lys-
Thr-Pro. To negate any possible phosphorylation of Thr744, we
mutated it to alanine in fl-DISC1. Such mutation failed to either
alter PDE4D3–fl-DISC1 complex formation or prevent disrup-
tion in cells challenged with forskolin/IBMX (Fig. 9B).
Binding at the PDE4B-specific sites on fl-DISC1 likely pro-
tects PDE4B from cAMP/PKA-mediated release because their
removal, by N-terminal deletion, generated a DISC1 truncate
that released PDE4B1 after elevation of intracellular cAMP (Fig.
6). This species may mimic the short 71 kDa DISC1 isoform,
which is the major DISC1 species expressed endogenously in
SHSY5Y cells (Millar et al., 2005). Although the sequence of the
71 kDa DISC1 isoform remains to be elucidated, it is believed to
beN-terminally truncated compared with fl-DISC1 (Millar et al.,
2004), which would be consistent with our studies.
What, then, is the PKA-mediated process that destabilizes
PDE4D3–fl-DISC1 complexes? One possibility is that PKA phos-
phorylation of a protein may either increase its affinity for bind-
ing PDE4D or generate an ability to bind PDE4D. Another is that
PKA phosphorylation of a protein alters its interaction with fl-
DISC1, thereby attenuating PDE4D3 binding. The resolution of
this will require a major proteomics investigation that is beyond
the remit of this study. However, the principle that PDE4 iso-
forms can redistribute dynamically between signaling scaffolds
has been firmly established for PDE4D5 sequestered to RACK1
and arrestin scaffolds (Lynch et al., 2005; Bolger et al., 2006).
This study reveals the complex nature of DISC1–PDE4 inter-
actions. The diversity of PDE4 subfamilies and DISC1 isoforms
has functional correlates exemplified in the different susceptibil-
ities of partnerships to be dissociated after cAMP elevation. fl-
DISC1 comprises a globular N-terminal head domain with a
C-terminal tail containing a series of coiled-coil domains (Millar
et al., 2000) (Fig. 3C). The head domain contains four of the five
putative PDE4B-specific contact sites (Fig. 3C), suggesting that
PDE4B binding is likely a major function of this region. Both cs1
and cs2 are located within regions of DISC1 that are well con-
served between species, consistent with their importance for
PDE4 interaction. Furthermore, exon 9, which encodes cs2, may
be alternatively spliced such that cs2 is absent from certainDISC1
transcripts (Ma et al., 2002; Millar et al., 2004), thereby compro-
mising PDE4 interaction. Alterations in DISC1 and PDE4 iso-
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form expression profiles therefore offer a means to reprogram
whether these proteins interact or DISC1-sequestered PDE4 is
released after cAMP elevation. Thus functional variation, genet-
ically determined, epigenetically programmed, or environmen-
tally cued, that influences isoform expression or binding affinity
within individual contact sites may be of importance in mental
illness. Although genetic studies have identified DISC1, PDE4B,
and PDE4D as risk factors for major mental illness, no definitive
causal variants, beyond chromosomal translocations (Millar et
al., 2005), have been identified in psychiatric patients. However
two point mutations in the mouse Disc1 gene confer behavioral,
brain structural, and pharmacological phenotypes related to
schizophrenia and depression (Clapcote et al., 2007). These mu-
tations are located within regions of mouse Disc1 corresponding
to the PDE4B-specific binding sites 4bss1 and 4bss2 of human
DISC1 (Fig. 3C) and both reduce Disc1 binding to PDE4B (Clap-
cote et al., 2007).We showhere that peptides encompassing these
regions bind PDE4B1 and substitutions (Ala/Pro) at Leu100,
which reflect the consequences of point mutations, attenuate
PDE4B1 interaction (Fig. 3F,G). Thus, genetic variation in either
DISC1 or PDE4 that alters their coexpression, dynamic associa-
tion, and thereby cAMP signalingmay be predicted to predispose
to psychopathology. Such aberrant interactions are a potential
target for novel drug and diagnostic development.
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